<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2023v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2024-06-03T09:14:59-04:00</ReturnTs>
    <TaxPeriodEndDt>2023-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>341602442</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>H &amp; J CERTIFIED PUBLIC ACCOUNTANTS INC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>7555 FREDLE DR STE 110</AddressLine1Txt>
        <CityNm>CONCORD</CityNm>
        <StateAbbreviationCd>OH</StateAbbreviationCd>
        <ZIPCd>44077</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2023-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>223611011</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>PLATELET DISORDER SUPPORT</BusinessNameLine1Txt>
        <BusinessNameLine2Txt>ASSOCIATION</BusinessNameLine2Txt>
      </BusinessName>
      <BusinessNameControlTxt>PLAT</BusinessNameControlTxt>
      <PhoneNum>4407469003</PhoneNum>
      <USAddress>
        <AddressLine1Txt>8751 BRECKSVILLE RD</AddressLine1Txt>
        <CityNm>BRECKSVILLE</CityNm>
        <StateAbbreviationCd>OH</StateAbbreviationCd>
        <ZIPCd>44141</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>CAROLINE KRUSE</PersonNm>
      <PersonTitleTxt>PRESIDENT AND CEO</PersonTitleTxt>
      <PhoneNum>4407469003</PhoneNum>
      <SignatureDt>2024-05-29</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>CAROLINE</PersonFirstNm>
        <PersonLastNm>KRUSE</PersonLastNm>
      </PersonFullName>
      <SSN>999009999</SSN>
    </SigningOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>true</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>ROLLAND B STANDISH</PreparerPersonNm>
      <PTIN>P00169705</PTIN>
      <PhoneNum>4409512997</PhoneNum>
      <PreparationDt>2024-05-29</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2023</TaxYr>
    <BuildTS>2023-04-26 12:10:37Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="9">
    <IRS990 documentId="RetDoc2" referenceDocumentId="RetDoc9">
      <PrincipalOfficerNm>PETER PRUITT</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>8751 BRECKSVILLE RD NO 150</AddressLine1Txt>
        <CityNm>CLEVELAND</CityNm>
        <StateAbbreviationCd>OH</StateAbbreviationCd>
        <ZIPCd>44141</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>2345345</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.PDSA.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>1998</FormationYr>
      <LegalDomicileStateCd>NJ</LegalDomicileStateCd>
      <ActivityOrMissionDesc>PDSA'S MISSION IS TO ENHANCE THE LIVES OF PEOPLE WITH IMMUNE THROMBOCYTOPENIA (ITP) AND OTHER PLATELET DISORDERS THROUGH EDUCATION, ADVOCACY, RESEARCH AND SUPPORT.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>8</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>8</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>8</TotalEmployeeCnt>
      <TotalVolunteersCnt>100</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>1681746</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>2171956</CYContributionsGrantsAmt>
      <CYProgramServiceRevenueAmt>0</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>15724</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>136105</CYInvestmentIncomeAmt>
      <PYOtherRevenueAmt>152858</PYOtherRevenueAmt>
      <CYOtherRevenueAmt>22922</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>1850328</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>2330983</CYTotalRevenueAmt>
      <PYGrantsAndSimilarPaidAmt>54000</PYGrantsAndSimilarPaidAmt>
      <CYGrantsAndSimilarPaidAmt>56000</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <PYSalariesCompEmpBnftPaidAmt>658001</PYSalariesCompEmpBnftPaidAmt>
      <CYSalariesCompEmpBnftPaidAmt>729691</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>115116</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>501927</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>709609</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>1213928</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>1495300</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>636400</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>835683</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>5188299</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>6370055</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>372657</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>326447</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>4815642</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>6043608</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>PDSA'S MISSION IS TO ENHANCE THE LIVES OF PEOPLE WITH IMMUNE THROMBOCYTOPENIA (ITP) AND OTHER PLATELET DISORDERS THROUGH EDUCATION, ADVOCACY, RESEARCH AND SUPPORT.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>1222399</ExpenseAmt>
      <GrantAmt>56000</GrantAmt>
      <Desc>2023 WAS AN EXTREMELY BUSY YEAR FOR PDSA AS WE CELEBRATED THE ORGANIZATION'S 25TH ANNIVERSARY. IT WAS OUR GOAL TO ORGANIZE WITH OUR VOLUNTEERS 25 AWARENESS EVENTS, INCLUDING FUNDRAISERS AND NATIONAL WALK/RUN "PUMP IT UP FOR PLATELETS- AND WE REACHED THAT GOAL. OUR 62 LOCAL SUPPORT GROUPS HELD A TOTAL OF 73 MEETINGS AND TWO FACILITATOR WORKSHOPS. ITP CONFERENCE 2023 TOOK PLACE IN CHICAGO AND WAS OUR 3RD LARGEST CONFERENCE IN 23 YEARS WITH 285 ATTENDEES, FROM 15 COUNTRIES AND 30 STATES. IN ADDITION, WE OFFERED A VIRTUAL CONFERENCE PLATFORM WITH 1,098 PDSA MEMBERS GIVEN ACCESS TO THE VIRTUAL CONTENT IN SEPTEMBER FOR ITP AWARENESS MONTH. PDSA HOSTED A WEBINAR WITH THE ITP SUPPORT ASSOCIATION IN THE UK AND TWO WORLD- RENOWNED ITP EXPERTS IN RECOGNITION OF GLOBAL ITP AWARENESS WEEK. PDSA ALSO HOSTED THE INTERNATIONAL ITP ALLIANCE MEETING AS PART OF ITP CONFERENCE 2023. FOURTEEN GLOBAL AMBASSADORS REPRESENTING 12 COUNTRIES PARTICIPATED IN THE MEETING. ON THE RESEARCH FRONT, PDSA STAFF ATTENDED, EXHIBITED AND PRESENTED EDUCATIONAL PROGRAMS AT A NUMBER OF SCIENTIFIC/MEDICAL MEETINGS INCLUDING AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY /ONCOLOGY (ASPHO), NATIONAL ORGANIZATION OF RARE DISORDERS (NORD) RARE DISEASE SUMMIT AND THE NORD LIVING RARE, LIVING STRONGER PATIENT/FAMILY FORUM, AND THE AMERICAN SOCIETY OF HEMATOLOGY/ONCOLOGY ANNUAL MEETING AND EXHIBITION (ASH). PDSA ALSO ORGANIZED AND HOSTED THE ASH ITP BREAKFAST AND ICON (ITP CONSORTIUM OF NORTH AMERICA) ANNUAL MEETING WITH 250 ATTENDEES. OUR ABSTRACTS ON PATIENT QUALITY OF LIFE WERE PRESENTED AT ASH, EHA (EUROPEAN HEMATOLOGY/ONCOLOGY ASSOCIATION) AND NORD. WE FUNDED FOUR INNOVATIVE PATIENT-CENTERED ITP RESEARCH STUDIES IN 2023. PDSA WAS VERY ACTIVE ON THE ADVOCACY FRONT, WITH STAFF AND MEDICAL ADVISORS MEETING WITH DIRECTORS FROM THE DIVISION OF BLOOD DISORDERS AT BOTH THE NHLBI (NATIONAL HEART, LUNG AND BLOOD INSTITUTE) AND THE CDC (CENTERS FOR DISEASE CONTROL AND PREVENTION). WE ORGANIZED TWO HILL DAYS IN WASHINGTON, DC, MEETING WITH 26 CONGRESSIONAL OFFICES TO EDUCATE THEM ON THE UNMET NEEDS AND BURDEN OF DISEASE OF ITP PATIENTS AND URGING THEM TO SUPPORT FEDERAL PROGRAMS FOR ITP. DUE TO OUR EFFORTS, THE DEPARTMENT OF HEALTH AND HUMAN SERVICES INCLUDED ITP REPORT LANGUAGE IN SENATE APPROPRIATIONS BILL - A FIRST THIS MEANS THAT CONGRESS HAS RECOGNIZED THE IMPORTANCE OF GREATER AWARENESS FOR ITP. PDSA STAFF AND OUR MEDICAL ADVISORS CONTINUED TO ANSWER PATIENT/CAREGIVER CALLS AND EMAILS VIA OUR ITP HELPLINE. THIS WAS ALL IN ADDITION TO PDSA'S REGULAR PROGRAMS AND RESOURCES, INCLUDING THE ITP POKE-R-CLUB FOR KIDS, COLLEGE SCHOLARSHIP PROGRAM, UPDATING AND TRANSLATING NUMEROUS EDUCATIONAL BOOKLETS, AND PRODUCING A 28-PAGE QUARTERLY NEWSLETTER AND MONTHLY E- NEWSLETTER.</Desc>
      <TotalProgramServiceExpensesAmt>1222399</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc10">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd referenceDocumentId="RetDoc1">true</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc4">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc4">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc4">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc4">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="RetDoc4">false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc4">false</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc4">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc4">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc4">false</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc4">false</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc4">true</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc4">true</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc4">false</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>true</ForeignOfficeInd>
      <ForeignActivitiesInd>false</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd>false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd>false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd referenceDocumentId="RetDoc5">false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd referenceDocumentId="RetDoc5">true</FundraisingActivitiesInd>
      <GamingActivitiesInd referenceDocumentId="RetDoc5">false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd referenceDocumentId="RetDoc6">true</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd referenceDocumentId="RetDoc6">true</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc7">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd referenceDocumentId="RetDoc8">false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd referenceDocumentId="RetDoc8">false</PYExcessBenefitTransInd>
      <LoanOutstandingInd referenceDocumentId="RetDoc8">false</LoanOutstandingInd>
      <GrantToRelatedPersonInd referenceDocumentId="RetDoc8">false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd referenceDocumentId="RetDoc8">false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd referenceDocumentId="RetDoc8">true</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd referenceDocumentId="RetDoc8">false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd>false</DisregardedEntityInd>
      <RelatedEntityInd>false</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>false</RelatedOrganizationCtrlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd>false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd>false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>1</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>true</BackupWthldComplianceInd>
      <EmployeeCnt>8</EmployeeCnt>
      <EmploymentTaxReturnsFiledInd>true</EmploymentTaxReturnsFiledInd>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>false</ForeignFinancialAccountInd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <Form8899Filedind>false</Form8899Filedind>
      <Form1098CFiledInd>false</Form1098CFiledInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>8</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>8</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>false</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>MD</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NJ</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>IL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>CA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NY</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>OH</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>FL</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>PA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>VA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>WA</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>NC</StatesWhereCopyOfReturnIsFldCd>
      <StatesWhereCopyOfReturnIsFldCd>KS</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>CAROLINE KRUSE</PersonNm>
        <PhoneNum>4407469003</PhoneNum>
        <USAddress>
          <AddressLine1Txt>8751 BRECKSVILLE RD NO 150</AddressLine1Txt>
          <CityNm>CLEVELAND</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>44141</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <Form990PartVIISectionAGrp>
        <PersonNm>CAROLINE KRUSE</PersonNm>
        <TitleTxt>PRESIDENT AN</TitleTxt>
        <AverageHoursPerWeekRt>40.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>186730</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>19332</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>PETER PRUITT</PersonNm>
        <TitleTxt>CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>KIM EVERETT</PersonNm>
        <TitleTxt>TREASURER</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>ROBERT FEINER</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MELISSA HILSABECK</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>LINDA MCGUIRL</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DALE PAYNTER</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BRUCE PRESCOTT</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DEREK ZIMMERMAN</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotalReportableCompFromOrgAmt>186730</TotalReportableCompFromOrgAmt>
      <TotalOtherCompensationAmt>19332</TotalOtherCompensationAmt>
      <IndivRcvdGreaterThan100KCnt>1</IndivRcvdGreaterThan100KCnt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <MembershipDuesAmt>148796</MembershipDuesAmt>
      <FundraisingAmt>152893</FundraisingAmt>
      <AllOtherContributionsAmt>1870267</AllOtherContributionsAmt>
      <TotalContributionsAmt>2171956</TotalContributionsAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>136105</TotalRevenueColumnAmt>
        <ExclusionAmt>136105</ExclusionAmt>
      </InvestmentIncomeGrp>
      <RoyaltiesRevenueGrp>
        <TotalRevenueColumnAmt>15200</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>15200</RelatedOrExemptFuncIncomeAmt>
      </RoyaltiesRevenueGrp>
      <FundraisingGrossIncomeAmt>9356</FundraisingGrossIncomeAmt>
      <ContriRptFundraisingEventAmt>152893</ContriRptFundraisingEventAmt>
      <FundraisingDirectExpensesAmt>9356</FundraisingDirectExpensesAmt>
      <GrossSalesOfInventoryAmt>10432</GrossSalesOfInventoryAmt>
      <CostOfGoodsSoldAmt>5006</CostOfGoodsSoldAmt>
      <NetIncomeOrLossGrp>
        <TotalRevenueColumnAmt>5426</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>5426</RelatedOrExemptFuncIncomeAmt>
      </NetIncomeOrLossGrp>
      <OtherRevenueMiscGrp>
        <Desc>MISCELLANEOUS</Desc>
        <TotalRevenueColumnAmt>2296</TotalRevenueColumnAmt>
        <ExclusionAmt>2296</ExclusionAmt>
      </OtherRevenueMiscGrp>
      <OtherRevenueTotalAmt>2296</OtherRevenueTotalAmt>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>2330983</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>20626</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>138401</ExclusionAmt>
      </TotalRevenueGrp>
      <GrantsToDomesticOrgsGrp>
        <TotalAmt>23000</TotalAmt>
        <ProgramServicesAmt>23000</ProgramServicesAmt>
      </GrantsToDomesticOrgsGrp>
      <GrantsToDomesticIndividualsGrp>
        <TotalAmt>33000</TotalAmt>
        <ProgramServicesAmt>33000</ProgramServicesAmt>
      </GrantsToDomesticIndividualsGrp>
      <CompCurrentOfcrDirectorsGrp>
        <TotalAmt>186730</TotalAmt>
        <ProgramServicesAmt>158721</ProgramServicesAmt>
        <ManagementAndGeneralAmt>18637</ManagementAndGeneralAmt>
        <FundraisingAmt>9372</FundraisingAmt>
      </CompCurrentOfcrDirectorsGrp>
      <OtherSalariesAndWagesGrp>
        <TotalAmt>434472</TotalAmt>
        <ProgramServicesAmt>296539</ProgramServicesAmt>
        <ManagementAndGeneralAmt>65884</ManagementAndGeneralAmt>
        <FundraisingAmt>72049</FundraisingAmt>
      </OtherSalariesAndWagesGrp>
      <PensionPlanContributionsGrp>
        <TotalAmt>13085</TotalAmt>
        <ProgramServicesAmt>9858</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1577</ManagementAndGeneralAmt>
        <FundraisingAmt>1650</FundraisingAmt>
      </PensionPlanContributionsGrp>
      <OtherEmployeeBenefitsGrp>
        <TotalAmt>44707</TotalAmt>
        <ProgramServicesAmt>31657</ProgramServicesAmt>
        <ManagementAndGeneralAmt>5816</ManagementAndGeneralAmt>
        <FundraisingAmt>7234</FundraisingAmt>
      </OtherEmployeeBenefitsGrp>
      <PayrollTaxesGrp>
        <TotalAmt>50697</TotalAmt>
        <ProgramServicesAmt>35899</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6595</ManagementAndGeneralAmt>
        <FundraisingAmt>8203</FundraisingAmt>
      </PayrollTaxesGrp>
      <FeesForServicesAccountingGrp>
        <TotalAmt>27514</TotalAmt>
        <ManagementAndGeneralAmt>27514</ManagementAndGeneralAmt>
      </FeesForServicesAccountingGrp>
      <FeesForSrvcInvstMgmntFeesGrp>
        <TotalAmt>12624</TotalAmt>
        <ManagementAndGeneralAmt>12624</ManagementAndGeneralAmt>
      </FeesForSrvcInvstMgmntFeesGrp>
      <FeesForServicesOtherGrp>
        <TotalAmt>137356</TotalAmt>
        <ProgramServicesAmt>131857</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3843</ManagementAndGeneralAmt>
        <FundraisingAmt>1656</FundraisingAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>78278</TotalAmt>
        <ProgramServicesAmt>60732</ProgramServicesAmt>
        <ManagementAndGeneralAmt>6311</ManagementAndGeneralAmt>
        <FundraisingAmt>11235</FundraisingAmt>
      </OfficeExpensesGrp>
      <InformationTechnologyGrp>
        <TotalAmt>20575</TotalAmt>
        <ProgramServicesAmt>16351</ProgramServicesAmt>
        <ManagementAndGeneralAmt>4224</ManagementAndGeneralAmt>
      </InformationTechnologyGrp>
      <OccupancyGrp>
        <TotalAmt>30732</TotalAmt>
        <ProgramServicesAmt>26785</ProgramServicesAmt>
        <ManagementAndGeneralAmt>2301</ManagementAndGeneralAmt>
        <FundraisingAmt>1646</FundraisingAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>38691</TotalAmt>
        <ProgramServicesAmt>37267</ProgramServicesAmt>
        <ManagementAndGeneralAmt>119</ManagementAndGeneralAmt>
        <FundraisingAmt>1305</FundraisingAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>324251</TotalAmt>
        <ProgramServicesAmt>324251</ProgramServicesAmt>
      </ConferencesMeetingsGrp>
      <DepreciationDepletionGrp>
        <TotalAmt>12426</TotalAmt>
        <ProgramServicesAmt>12426</ProgramServicesAmt>
      </DepreciationDepletionGrp>
      <InsuranceGrp>
        <TotalAmt>4842</TotalAmt>
        <ProgramServicesAmt>3269</ProgramServicesAmt>
        <ManagementAndGeneralAmt>1573</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>EXHIBIT EXPENSES</Desc>
        <TotalAmt>16279</TotalAmt>
        <ProgramServicesAmt>16279</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>SCHOLARSHIPS</Desc>
        <TotalAmt>3741</TotalAmt>
        <ProgramServicesAmt>3741</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>STATE REG FEES</Desc>
        <TotalAmt>2300</TotalAmt>
        <ProgramServicesAmt>767</ProgramServicesAmt>
        <ManagementAndGeneralAmt>767</ManagementAndGeneralAmt>
        <FundraisingAmt>766</FundraisingAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>1495300</TotalAmt>
        <ProgramServicesAmt>1222399</ProgramServicesAmt>
        <ManagementAndGeneralAmt>157785</ManagementAndGeneralAmt>
        <FundraisingAmt>115116</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>665561</BOYAmt>
        <EOYAmt>433303</EOYAmt>
      </CashNonInterestBearingGrp>
      <SavingsAndTempCashInvstGrp>
        <BOYAmt>4190799</BOYAmt>
        <EOYAmt>1138829</EOYAmt>
      </SavingsAndTempCashInvstGrp>
      <AccountsReceivableGrp>
        <BOYAmt>277012</BOYAmt>
        <EOYAmt>129925</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>7832</BOYAmt>
        <EOYAmt>29364</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <InvestmentsPubTradedSecGrp>
        <EOYAmt>4617227</EOYAmt>
      </InvestmentsPubTradedSecGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>47095</BOYAmt>
        <EOYAmt>21407</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>5188299</BOYAmt>
        <EOYAmt>6370055</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>140175</BOYAmt>
        <EOYAmt>145780</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>232482</BOYAmt>
        <EOYAmt>180667</EOYAmt>
      </DeferredRevenueGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>372657</BOYAmt>
        <EOYAmt>326447</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>4334064</BOYAmt>
        <EOYAmt>5162009</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>481578</BOYAmt>
        <EOYAmt>881599</EOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>4815642</BOYAmt>
        <EOYAmt>6043608</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>5188299</BOYAmt>
        <EOYAmt>6370055</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>835683</ReconcilationRevenueExpnssAmt>
      <NetUnrlzdGainsLossesInvstAmt>392283</NetUnrlzdGainsLossesInvstAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <SeparateBasisFinclStmtInd>X</SeparateBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc10">
      <PublicOrganization170Ind>X</PublicOrganization170Ind>
      <GiftsGrantsContriRcvd170Grp>
        <CurrentTaxYearMinus4YearsAmt>1560511</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1906196</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1740329</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1681746</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2171956</CurrentTaxYearAmt>
        <TotalAmt>9060738</TotalAmt>
      </GiftsGrantsContriRcvd170Grp>
      <TotalCalendarYear170Grp>
        <CurrentTaxYearMinus4YearsAmt>1560511</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1906196</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>1740329</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1681746</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>2171956</CurrentTaxYearAmt>
        <TotalAmt>9060738</TotalAmt>
      </TotalCalendarYear170Grp>
      <SubstantialContributorsTotAmt>3161393</SubstantialContributorsTotAmt>
      <PublicSupportTotal170Amt>5899345</PublicSupportTotal170Amt>
      <GrossInvestmentIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>14332</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>81014</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>74993</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>15724</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>136105</CurrentTaxYearAmt>
        <TotalAmt>322168</TotalAmt>
      </GrossInvestmentIncome170Grp>
      <OtherIncome170Grp>
        <CurrentTaxYearMinus4YearsAmt>6872</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>35595</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>11716</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>13168</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>11652</CurrentTaxYearAmt>
        <TotalAmt>79003</TotalAmt>
      </OtherIncome170Grp>
      <TotalSupportAmt>9461909</TotalSupportAmt>
      <GrossReceiptsRltdActivitiesAmt>71962</GrossReceiptsRltdActivitiesAmt>
      <PublicSupportCY170Pct>0.62350</PublicSupportCY170Pct>
      <PublicSupportPY170Pct>0.54700</PublicSupportPY170Pct>
      <ThirtyThrPctSuprtTestsCY170Ind>X</ThirtyThrPctSuprtTestsCY170Ind>
      <Form990ScheduleAPartVIGrp>
        <FormAndLineReferenceDesc>PART II, LINE 10</FormAndLineReferenceDesc>
        <ExplanationTxt>MISC REVENUE 67,351</ExplanationTxt>
      </Form990ScheduleAPartVIGrp>
    </IRS990ScheduleA>
    <IRS990ScheduleB documentId="RetDoc1">
      <ContributorInformationGrp>
        <ContributorNum>RESTRICTED</ContributorNum>
        <ContributorBusinessName>
          <BusinessNameLine1>RESTRICTED</BusinessNameLine1>
        </ContributorBusinessName>
        <ContributorUSAddress>
          <AddressLine1>RESTRICTED</AddressLine1>
          <AddressLine2>RESTRICTED</AddressLine2>
          <City>RESTRICTED</City>
          <State>RESTRICTED</State>
          <ZIPCode>RESTRICTED</ZIPCode>
        </ContributorUSAddress>
        <TotalContributionsAmt>RESTRICTED</TotalContributionsAmt>
      </ContributorInformationGrp>
    </IRS990ScheduleB>
    <IRS990ScheduleD documentId="RetDoc4">
      <FootnoteTextInd>X</FootnoteTextInd>
      <TotalRevEtcAuditedFinclStmtAmt>2750252</TotalRevEtcAuditedFinclStmtAmt>
      <NetUnrealizedGainsInvstAmt>392283</NetUnrealizedGainsInvstAmt>
      <OtherRevenueAmt>26986</OtherRevenueAmt>
      <RevenueNotReportedAmt>419269</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>2330983</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>2330983</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>1522286</TotExpnsEtcAuditedFinclStmtAmt>
      <OtherExpensesIncludedAmt>26986</OtherExpensesIncludedAmt>
      <ExpensesNotReportedAmt>26986</ExpensesNotReportedAmt>
      <ExpensesSubtotalAmt>1495300</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>1495300</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PAGE 3, PART X</FormAndLineReferenceDesc>
        <ExplanationTxt>PDSA IS INCORPORATED AS A NOT-FOR-PROFIT THAT IS EXEMPT FROM FEDERAL INCOME TAXES UNDER INTERNAL REVENUE CODE SECTION 501(C)(3) AND IS NOT CONSIDERED A PRIVATE FOUNDATION UNDER SECTION 509(A)(1). PDSA CURRENTLY HAS NO UNRELATED BUSINESS INCOME. ACCORDINGLY, NO PROVISION FOR INCOME TAXES HAS BEEN RECORDED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PAGE 4, PART XI, LINE 2D</FormAndLineReferenceDesc>
        <ExplanationTxt>COGS NET W/REV ON 990 5,006 DIRECT DONOR BENEFITS 9,356 INVESTMENT MGMT FEES 12,624</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PAGE 4, PART XII, LINE 2D</FormAndLineReferenceDesc>
        <ExplanationTxt>COGS NET W/REV ON 990 5,006 DIRECT DONOR BENEFITS 9,356 INVESTMENT MGMT FEES 12,624</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleG documentId="RetDoc5">
      <FundraisingEventInformationGrp>
        <Event1Nm>WALK/RUN EVENTS</Event1Nm>
        <GrossReceiptsEvent1Amt>162249</GrossReceiptsEvent1Amt>
        <CharitableContriEvent1Amt>152893</CharitableContriEvent1Amt>
        <GrossRevenueEvent1Amt>9356</GrossRevenueEvent1Amt>
        <RentFacilityCostsEvent1Amt>975</RentFacilityCostsEvent1Amt>
        <OtherDirectExpensesEvent1Amt>8381</OtherDirectExpensesEvent1Amt>
        <GrossReceiptsTotalAmt>162249</GrossReceiptsTotalAmt>
        <CharitableContributionsTotAmt>152893</CharitableContributionsTotAmt>
        <GrossRevenueTotalEventsAmt>9356</GrossRevenueTotalEventsAmt>
        <RentFcltyCostsTotalEventsAmt>975</RentFcltyCostsTotalEventsAmt>
        <OthDirectExpnssTotalEventsAmt>8381</OthDirectExpnssTotalEventsAmt>
        <DirectExpenseSummaryEventsAmt>9356</DirectExpenseSummaryEventsAmt>
      </FundraisingEventInformationGrp>
    </IRS990ScheduleG>
    <IRS990ScheduleI documentId="RetDoc6">
      <GrantRecordsMaintainedInd>true</GrantRecordsMaintainedInd>
      <RecipientTable>
        <RecipientBusinessName>
          <BusinessNameLine1Txt>UNIVERSITY OF WASHINGTON</BusinessNameLine1Txt>
        </RecipientBusinessName>
        <USAddress>
          <AddressLine1Txt>1410 NE CAMPUS PKWY</AddressLine1Txt>
          <CityNm>SEATTLE</CityNm>
          <StateAbbreviationCd>WA</StateAbbreviationCd>
          <ZIPCd>98195</ZIPCd>
        </USAddress>
        <RecipientEIN>916001537</RecipientEIN>
        <IRCSectionDesc>C3</IRCSectionDesc>
        <CashGrantAmt>20000</CashGrantAmt>
        <PurposeOfGrantTxt>ITP RESEARCH</PurposeOfGrantTxt>
      </RecipientTable>
      <Total501c3OrgCnt>2</Total501c3OrgCnt>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>COLLEGE SCHOLARSHIPS</GrantTypeTxt>
        <RecipientCnt>4</RecipientCnt>
        <NonCashAssistanceAmt>3000</NonCashAssistanceAmt>
        <NonCashAssistanceDesc>DIRECT TO UNIV</NonCashAssistanceDesc>
      </GrantsOtherAsstToIndivInUSGrp>
      <GrantsOtherAsstToIndivInUSGrp>
        <GrantTypeTxt>RESEARCH AWARDS</GrantTypeTxt>
        <RecipientCnt>2</RecipientCnt>
        <CashGrantAmt>30000</CashGrantAmt>
      </GrantsOtherAsstToIndivInUSGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE I, PAGE 1, PART I, LINE 2</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION OFFERS SCHOLARSHIPS TO INDIVIDUALS WHO WISH TO ATTEND THE ORGANIZATION'S ANNUAL CONFERENCE. INDIVIDUALS WHO APPLY ARE CHOSEN BASED ON THEIR CONNECTION TO ITP OR ANOTHER PLATELET DISORDER, DESIRE TO ATTEND THE CONFERENCE, AS WELL AS THEIR NEED FOR FINANCIAL SUPPORT. THE PDSA COLLEGE SCHOLARSHIP PROGRAM PROVIDES FINANCIAL ASSISTANCE TO SENIOR HIGH SCHOOL STUDENTS, COLLEGE STUDENTS OR ADULTS INTERESTED IN CONTINUING EDUCAITON WHO ARE SUFFERING FROM ITP OR A SIMILAR INHERITED OR NON-INHERITED PLATELET DISORDER. THREE MONETARY AND FIVE BOOK SCHOLARSHIPS TOTALING 4,500 ARE AWARDED ANNUALY. SCHOLARSHIP RECIPENTS ARE SELECTED BY A PATIENT PANEL. IN 2016, PDSA ESTABLISHED RESEARCH GUIDELINES WITH THE GOAL OF FUNDING THE MOST PROMISING RESEARCH PROJECTS BY INVESTIGATORS TO FURTHER UNDERSTAND THE PATHOGENISIS AND MANAGEMENT OF PRIMARY ITP, HAVE THE POTENTIAL TO RAISE THE QUALITY OF LIFE FOR ITP PATIENTS, AND LEAD TO NEW THERAPIES AND A CURE. PROPOSALS MUST INCLUDE BUDGET AND USE OF FUNDS. TWO AWARDS OF 20,000 EACH ARE GIVEN ANNUALY. PROGRESS REPORTS ARE REQUIRED. RESEARCH FINDINGS IS PRESENTED AT THE ANNUAL ITP CONFERENCE. IN 2017, PDSA ESTABLISHED A RESEARCH PROGRAM TO SUPPORT EXCELLENCE IN ACADEMIC ITP RESEARCH FOR UNDERGRADUATES, MEDICAL OR GRADUATE STUDENTS INTERESTED IN THE LABORATORY OR CLINICAL STUDY OF IMMUNE THROMBOCYTOPENIA. ONE 10,000 SCHOLARSHIP IS AWARDED ANNUALLY. BOTH RESEARCH PROGRAMS ARE REVIEWED AND SELECTED BY A COMMITTEE COMPRISED OF PATIENTS AND PDSA MEDICAL ADVISORS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleI>
    <IRS990ScheduleJ documentId="RetDoc7">
      <SeverancePaymentInd>false</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>false</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>false</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>false</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>false</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>CAROLINE KRUSE</PersonNm>
        <TitleTxt>PRESIDENT AND CEO</TitleTxt>
        <BaseCompensationFilingOrgAmt>159230</BaseCompensationFilingOrgAmt>
        <BonusFilingOrganizationAmount>27500</BonusFilingOrganizationAmount>
        <DeferredCompensationFlngOrgAmt>19332</DeferredCompensationFlngOrgAmt>
        <TotalCompensationFilingOrgAmt>206062</TotalCompensationFilingOrgAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
    </IRS990ScheduleJ>
    <IRS990ScheduleL documentId="RetDoc8">
      <BusTrInvolveInterestedPrsnGrp>
        <NameOfInterested>
          <PersonNm>ALEXANDRA KRUSE</PersonNm>
        </NameOfInterested>
        <RelationshipDescriptionTxt>FAMILY MEMBER</RelationshipDescriptionTxt>
        <TransactionDesc>COMPENSATION</TransactionDesc>
        <SharingOfRevenuesInd>false</SharingOfRevenuesInd>
      </BusTrInvolveInterestedPrsnGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE L, PART V</FormAndLineReferenceDesc>
        <ExplanationTxt>COMPENSATION TO ALEXANDRA KRUSE FOR RESEARCH ADVISORY SERVICES; DAUGHTER OF CAROLINE KRUSE, THE ORGANIZATION'S PRESIDENT AND CEO.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleL>
    <IRS990ScheduleO documentId="RetDoc9">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>2023 WAS AN EXTREMELY BUSY YEAR FOR PDSA AS WE CELEBRATED THE ORGANIZATION'S 25TH ANNIVERSARY. IT WAS OUR GOAL TO ORGANIZE WITH OUR VOLUNTEERS 25 AWARENESS EVENTS, INCLUDING FUNDRAISERS AND NATIONAL WALK/RUN "PUMP IT UP FOR PLATELETS- AND WE REACHED THAT GOAL. OUR 62 LOCAL SUPPORT GROUPS HELD A TOTAL OF 73 MEETINGS AND TWO FACILITATOR WORKSHOPS. ITP CONFERENCE 2023 TOOK PLACE IN CHICAGO AND WAS OUR 3RD LARGEST CONFERENCE IN 23 YEARS WITH 285 ATTENDEES, FROM 15 COUNTRIES AND 30 STATES. IN ADDITION, WE OFFERED A VIRTUAL CONFERENCE PLATFORM WITH 1,098 PDSA MEMBERS GIVEN ACCESS TO THE VIRTUAL CONTENT IN SEPTEMBER FOR ITP AWARENESS MONTH. PDSA HOSTED A WEBINAR WITH THE ITP SUPPORT ASSOCIATION IN THE UK AND TWO WORLD- RENOWNED ITP EXPERTS IN RECOGNITION OF GLOBAL ITP AWARENESS WEEK. PDSA ALSO HOSTED THE INTERNATIONAL ITP ALLIANCE MEETING AS PART OF ITP CONFERENCE 2023. FOURTEEN GLOBAL AMBASSADORS REPRESENTING 12 COUNTRIES PARTICIPATED IN THE MEETING. ON THE RESEARCH FRONT, PDSA STAFF ATTENDED, EXHIBITED AND PRESENTED EDUCATIONAL PROGRAMS AT A NUMBER OF SCIENTIFIC/MEDICAL MEETINGS INCLUDING AMERICAN SOCIETY OF PEDIATRIC HEMATOLOGY /ONCOLOGY (ASPHO), NATIONAL ORGANIZATION OF RARE DISORDERS (NORD) RARE DISEASE SUMMIT AND THE NORD LIVING RARE, LIVING STRONGER PATIENT/FAMILY FORUM, AND THE AMERICAN SOCIETY OF HEMATOLOGY/ONCOLOGY ANNUAL MEETING AND EXHIBITION (ASH). PDSA ALSO ORGANIZED AND HOSTED THE ASH ITP BREAKFAST AND ICON (ITP CONSORTIUM OF NORTH AMERICA) ANNUAL MEETING WITH 250 ATTENDEES. OUR ABSTRACTS ON PATIENT QUALITY OF LIFE WERE PRESENTED AT ASH, EHA (EUROPEAN HEMATOLOGY/ONCOLOGY ASSOCIATION) AND NORD. WE FUNDED FOUR INNOVATIVE PATIENT-CENTERED ITP RESEARCH STUDIES IN 2023. PDSA WAS VERY ACTIVE ON THE ADVOCACY FRONT, WITH STAFF AND MEDICAL ADVISORS MEETING WITH DIRECTORS FROM THE DIVISION OF BLOOD DISORDERS AT BOTH THE NHLBI (NATIONAL HEART, LUNG AND BLOOD INSTITUTE) AND THE CDC (CENTERS FOR DISEASE CONTROL AND PREVENTION). WE ORGANIZED TWO HILL DAYS IN WASHINGTON, DC, MEETING WITH 26 CONGRESSIONAL OFFICES TO EDUCATE THEM ON THE UNMET NEEDS AND BURDEN OF DISEASE OF ITP PATIENTS AND URGING THEM TO SUPPORT FEDERAL PROGRAMS FOR ITP. DUE TO OUR EFFORTS, THE DEPARTMENT OF HEALTH AND HUMAN SERVICES INCLUDED ITP REPORT LANGUAGE IN SENATE APPROPRIATIONS BILL - A FIRST THIS MEANS THAT CONGRESS HAS RECOGNIZED THE IMPORTANCE OF GREATER AWARENESS FOR ITP. PDSA STAFF AND OUR MEDICAL ADVISORS CONTINUED TO ANSWER PATIENT/CAREGIVER CALLS AND EMAILS VIA OUR ITP HELPLINE. THIS WAS ALL IN ADDITION TO PDSA'S REGULAR PROGRAMS AND RESOURCES, INCLUDING THE ITP POKE-R-CLUB FOR KIDS, COLLEGE SCHOLARSHIP PROGRAM, UPDATING AND TRANSLATING NUMEROUS EDUCATIONAL BOOKLETS, AND PRODUCING A 28-PAGE QUARTERLY NEWSLETTER AND MONTHLY E- NEWSLETTER.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>PRIOR TO FILING, THE FORM 990 IS PRESENTED TO THE EXECUTIVE DIRECTOR AND FINANCE STAFF FOR REVIEW AND APPROVAL. THE FORM 990 IS THEN ELECTRONICALLY DISTRIBUTED TO THE BOARD OF DIRECTORS IN ADVANCE OF FILING. A BOARD OFFICER SIGNS THE 990 (OR 8879-EO) AND THE 990 IS ELECTRONICALLY FILED.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>EACH YEAR, THE BOARD MEMBERS ARE ASKED TO REVIEW THE ORGANIZATION'S CONFLICT OF INTEREST POLICY. AMONG OTHER THINGS, THE POLICY MAKES CLEAR THAT ALL DECISIONS OF THE BOARD, OFFICERS, AND EMPLOYEES OF THE ORGANIZATION ARE MADE SOLELY ON THE BASIS OF A DESIRE TO PROMOTE THE BEST INTEREST OF THE ORGANIZATION AND THE PUBLIC GOOD. THE CONFLICT OF INTEREST STATEMENT REQUESTS BOARD MEMBERS TO IDENTIFY TO THE BEST OF THEIR KNOWLEDGE AFFILIATIONS WITH ORGANIZATIONS THAT MAY BE POTENTIALLY RELATED TO THE FINANCIALS OR OTHER SUBSTANTIVE OPERATIONS OF THE ORGANIZATION. THEY ARE ALSO ASKED TO IDENTIFY CIRCUMSTANCES INVOLVING EITHER THEMSELVES, OR A MEMBER OF THEIR EXTENDED FAMILY, THAT MAY BE CONSTRUED AS A CONFLICT OF INTEREST. AT THE STAFF LEVEL, THE ORGANIZATION'S PERSONNEL ALSO ENSURE THAT THERE ARE NO CONFLICTS OF INTEREST WHEN CONSIDERING THE ENGAGEMENT OF A NEW VENDOR. IF A POTENTIAL CONFLICT IS IDENTIFIED, APPROPRIATE STEPS ARE TAKEN TO BOTH ASSESS THE NATURE OF THE POTENTIAL CONFLICT AND, SUBSEQUENTLY, TO ENSURE THAT THE POSSIBILITY OF AN ACTUAL CONFLICT IS MITIGATED. SUCH MITIGATION IS MANAGED AND THE LETTER AND SPIRIT OF THE CONFLICTS POLICY ARE UPHELD.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>THE EXECUTIVE COMMITTEE ANNUALLY EVALUATES THE PERFORMANCE OF THE EXECUTIVE DIRECTOR. COMPENSATION IS BASED ON PERFORMANCE AND COMPARED TO OTHER AREA MISSION-COMPARABLE ORGANIZATIONS OF SIMILAR SIZE. COMPENSATION FOR STAFF WITHIN THE ORGANIZATION IS DETERMINED BY THE EXECUTIVE DIRECTOR. THE LEVEL OF COMPENSATION IS SET BASED ON PERFORMANCE AND IN RELATION TO OTHER AREA MISSION-COMPARABLE ORGANIZATIONS OF SIMILAR SIZE. THIS COMPENSATION IS A COMPONENT OF THE BUDGET, WHICH IS REVIEWED AND APPROVED BY THE FINANCE COMMITTEE AND ALSO BY THE BOARD AS A WHOLE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 17</FormAndLineReferenceDesc>
        <ExplanationTxt>KANSAS</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>THE ORGANIZATION'S GOVERNING DOCUMENTS, FORM 1023, FORM 990 CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST. THE FORM 990, WITHOUT SCHEDULE B) CAN ALSO BE FOUND ON SEVERAL PUBLICLY-ACCESSIBLE WEBSITES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9</FormAndLineReferenceDesc>
        <ExplanationTxt>COGS NET W/REV ON 990 5,006 DIRECT DONOR BENEFITS 9,356 INVESTMENT MGMT FEES 12,624 COGS NET W/REV ON 990 -5,006 DIRECT DONOR BENEFITS -9,356 INVESTMENT MGMT FEES -12,624</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
  </ReturnData>
</Return>
